{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:03:50Z","timestamp":1784077430986,"version":"3.55.0"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:00:00Z","timestamp":1784073600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    While systemic immune dysregulation is well-documented in HIV infection, its impact on blood and respiratory tract viromes remains poorly understood. This study characterizes HIV-associated alterations in viral communities and examines their clinical relevance. Using viral metagenomics, we compare 203 ART-treated HIV-positive individuals and 120 healthy controls. HIV infection significantly restructures the blood virome, shifting from bacteriophage dominance (96.2% in controls) to eukaryotic virus predominance (69.1%). Increased alpha diversity, significant \u03b2-diversity divergence, and heightened dispersion heterogeneity are observed in HIV cases. Consistent enrichment of\n                    <jats:italic>Flaviviridae<\/jats:italic>\n                    ,\n                    <jats:italic>Parvoviridae<\/jats:italic>\n                    , and\n                    <jats:italic>Anelloviridae<\/jats:italic>\n                    is detected. Throat viromes maintain phage dominance (&gt;90%) but exhibit strain-level diversification, including\n                    <jats:italic>Microviridae<\/jats:italic>\n                    proliferation. Network analysis reveals\n                    <jats:italic>Retroviridae-Anelloviridae<\/jats:italic>\n                    co-dynamics (r\u2009=\u2009+0.562) and identifies\n                    <jats:italic>Picobirnaviridae<\/jats:italic>\n                    as a key interactor. Functional analysis shows enriched viral replication and host modulation genes. Compartment-specific disruption patterns nominate Pegivirus C, parvovirus B19, and Anelloviruses as potential biomarkers. Cross-kingdom viral interactions suggest novel mechanisms influencing disease progression and support future virome-targeting adjunct therapies.\n                  <\/jats:p>","DOI":"10.1038\/s42003-026-10221-z","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T01:02:35Z","timestamp":1778202155000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["HIV-driven virome dysbiosis unveils distinct virome features and inter-viral correlations in blood and respiratory niches"],"prefix":"10.1038","volume":"9","author":[{"given":"Wang","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingyue","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anhua","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linjie","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2416-7708","authenticated-orcid":false,"given":"Youhua","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7607-700X","authenticated-orcid":false,"given":"Shaokun","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2661-2067","authenticated-orcid":false,"given":"Chenglin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"10221_CR1","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1111\/imr.12066","volume":"254","author":"AA Okoye","year":"2013","unstructured":"Okoye, A. A. & Picker, L. J. CD4(+) T-cell depletion in HIV infection: mechanisms of immunological failure. Immunol. Rev. 254, 54\u201364 (2013).","journal-title":"Immunol. Rev."},{"key":"10221_CR2","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/7316456","volume":"2021","author":"T Lv","year":"2021","unstructured":"Lv, T., Cao, W. & Li, T. HIV-related immune activation and inflammation: current understanding and strategies. J. Immunol. Res. 2021, 7316456 (2021).","journal-title":"J. Immunol. Res."},{"key":"10221_CR3","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1126\/science.6189183","volume":"220","author":"F Barr\u00e9-Sinoussi","year":"1983","unstructured":"Barr\u00e9-Sinoussi, F. et al. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220, 868\u2013871 (1983).","journal-title":"Science"},{"key":"10221_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59242-y","volume":"16","author":"H Lin","year":"2025","unstructured":"Lin, H. et al. Targeted plasma proteomics reveals organ damage signatures of AIDS- and noncommunicable disease-related deaths in people with HIV. Nat. Commun. 16, 3877 (2025).","journal-title":"Nat. Commun."},{"key":"10221_CR5","doi-asserted-by":"publisher","first-page":"83","DOI":"10.5334\/aogh.4277","volume":"89","author":"E Kumah","year":"2023","unstructured":"Kumah, E., Boakye, D. S., Boateng, R. & Agyei, E. Advancing the global fight against HIV\/aids: strategies, barriers, and the road to eradication. Ann. Glob. Health 89, 83 (2023).","journal-title":"Ann. Glob. Health"},{"key":"10221_CR6","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1038\/s41392-024-01946-6","volume":"9","author":"Z Ma","year":"2024","unstructured":"Ma, Z., Zuo, T., Frey, N. & Rangrez, A. Y. A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation. Signal Transduct. Target. Ther. 9, 237 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"10221_CR7","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.chom.2016.02.011","volume":"19","author":"CL Monaco","year":"2016","unstructured":"Monaco, C. L. et al. Altered virome and bacterial microbiome in human immunodeficiency virus-associated acquired immunodeficiency syndrome. Cell Host Microbe 19, 311\u2013322 (2016).","journal-title":"Cell Host Microbe"},{"key":"10221_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-25979-5","volume":"12","author":"P Villoslada-Blanco","year":"2022","unstructured":"Villoslada-Blanco, P. et al. Impact of HIV infection and integrase strand transfer inhibitors-based treatment on the gut virome. Sci. Rep. 12, 21658 (2022).","journal-title":"Sci. Rep."},{"key":"10221_CR9","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1038\/s41564-021-00928-6","volume":"6","author":"S Nayfach","year":"2021","unstructured":"Nayfach, S. et al. Metagenomic compendium of 189,680 DNA viruses from the human gut microbiome. Nat. Microbiol. 6, 960\u2013970 (2021).","journal-title":"Nat. Microbiol."},{"key":"10221_CR10","doi-asserted-by":"publisher","first-page":"1680","DOI":"10.3389\/fmicb.2018.01680","volume":"9","author":"S Pan","year":"2018","unstructured":"Pan, S. et al. Identification of a torque teno mini virus (TTMV) in Hodgkin\u2019s Lymphoma patients. Front. Microbiol. 9, 1680 (2018).","journal-title":"Front. Microbiol."},{"key":"10221_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/COH.0000000000000434","volume":"13","author":"WLA Koay","year":"2018","unstructured":"Koay, W. L. A., Siems, L. V. & Persaud, D. The microbiome and HIV persistence: implications for viral remission and cure. Curr. Opin. HIV AIDS 13, 61\u201368 (2018).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10221_CR12","doi-asserted-by":"publisher","unstructured":"G\u00e1sp\u00e1r, Z., Nagavci, B., Szab\u00f3, B. G. & Lakatos, B. Gut microbiome alteration in HIV\/AIDS and the role of antiretroviral therapy\u2014a scoping review. Microorganisms 12, https:\/\/doi.org\/10.3390\/microorganisms12112221 (2024).","DOI":"10.3390\/microorganisms12112221"},{"key":"10221_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/21505594.2025.2467168","volume":"16","author":"Y Ma","year":"2025","unstructured":"Ma, Y. et al. Short-term antiretroviral therapy may not correct the dysregulations of plasma virome and cytokines induced by HIV-1 infection. Virulence 16, 2467168 (2025).","journal-title":"Virulence"},{"key":"10221_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-024-01925-7","volume":"12","author":"C Boukadida","year":"2024","unstructured":"Boukadida, C. et al. Alterations of the gut microbiome in HIV infection highlight human anelloviruses as potential predictors of immune recovery. Microbiome 12, 204 (2024).","journal-title":"Microbiome"},{"key":"10221_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-63158-y","volume":"16","author":"EA Kaelin","year":"2025","unstructured":"Kaelin, E. A. et al. Longitudinal cervicovaginal bacteriome and virome alterations associate with discordant shedding and ART duration in women living with HIV in Peru. Nat. Commun. 16, 7904 (2025).","journal-title":"Nat. Commun."},{"key":"10221_CR16","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/COH.0000000000000870","volume":"19","author":"AM Ortiz","year":"2024","unstructured":"Ortiz, A. M. & Brenchley, J. M. Untangling the role of the microbiome across the stages of HIV disease. Curr. Opin. HIV AIDS 19, 221\u2013227 (2024).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10221_CR17","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1002\/cpt.363","volume":"99","author":"SX Li","year":"2016","unstructured":"Li, S. X. et al. Complexities of gut microbiome dysbiosis in the context of HIV infection and antiretroviral therapy. Clin. Pharmacol. Ther. 99, 600\u2013611 (2016).","journal-title":"Clin. Pharmacol. Ther."},{"key":"10221_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/COH.0000000000000241","volume":"11","author":"A Boulougoura","year":"2016","unstructured":"Boulougoura, A. & Sereti, I. HIV infection and immune activation: the role of coinfections. Curr. Opin. HIV AIDS 11, 191\u2013200 (2016).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10221_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-73870-2","volume":"14","author":"L Tarancon-Diez","year":"2024","unstructured":"Tarancon-Diez, L. et al. Torque teno virus: a potential marker of immune reconstitution in youths with vertically acquired HIV. Sci. Rep. 14, 24691 (2024).","journal-title":"Sci. Rep."},{"key":"10221_CR20","doi-asserted-by":"publisher","unstructured":"Wong-Rolle, A. et al. Spatial meta-transcriptomics reveal associations of intratumor bacteria burden with lung cancer cells showing a distinct oncogenic signature. J. Immunother. Cancer 10, https:\/\/doi.org\/10.1136\/jitc-2022-004698 (2022).","DOI":"10.1136\/jitc-2022-004698"},{"key":"10221_CR21","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1080\/14787210.2016.1206469","volume":"14","author":"MB Lawani","year":"2016","unstructured":"Lawani, M. B. & Morris, A. The respiratory microbiome of HIV-infected individuals. Expert Rev. Anti Infective Ther. 14, 719\u2013729 (2016).","journal-title":"Expert Rev. Anti Infective Ther."},{"key":"10221_CR22","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/all.15634","volume":"78","author":"J Rovira Rubi\u00f3","year":"2023","unstructured":"Rovira Rubi\u00f3, J. et al. Respiratory virome profiles reflect antiviral immune responses. Allergy 78, 1258\u20131268 (2023).","journal-title":"Allergy"},{"key":"10221_CR23","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.3389\/fimmu.2019.01551","volume":"10","author":"N Li","year":"2019","unstructured":"Li, N., Ma, W. T., Pang, M., Fan, Q. L. & Hua, J. L. The commensal microbiota and viral infection: a comprehensive review. Front. Immunol. 10, 1551 (2019).","journal-title":"Front. Immunol."},{"key":"10221_CR24","doi-asserted-by":"publisher","unstructured":"Timmerman, A. L., Sch\u00f6nert, A. L. M. & van der Hoek, L. Anelloviruses versus human immunity: how do we control these viruses? FEMS Microbiol. Rev. 48, https:\/\/doi.org\/10.1093\/femsre\/fuae005 (2024).","DOI":"10.1093\/femsre\/fuae005"},{"key":"10221_CR25","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1038\/s41586-024-07899-8","volume":"633","author":"JCO Mifsud","year":"2024","unstructured":"Mifsud, J. C. O. et al. Mapping glycoprotein structure reveals Flaviviridae evolutionary history. Nature 633, 695\u2013703 (2024).","journal-title":"Nature"},{"key":"10221_CR26","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1038\/s41586-023-06301-3","volume":"619","author":"AV Sherwood","year":"2023","unstructured":"Sherwood, A. V. et al. Hepatitis C virus RNA is 5\u2019-capped with flavin adenine dinucleotide. Nature 619, 811\u2013818 (2023).","journal-title":"Nature"},{"key":"10221_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-023-43158-y","volume":"13","author":"H Jiang","year":"2023","unstructured":"Jiang, H. et al. The epidemiological and genetic characteristics of human parvovirus B19 in patients with febrile rash illnesses in China. Sci. Rep. 13, 15913 (2023).","journal-title":"Sci. Rep."},{"key":"10221_CR28","doi-asserted-by":"publisher","unstructured":"Mendes-de-Almeida, D. P. et al. Clinical presentation of parvovirus B19 infection in adults living with HIV\/AIDS: a case series. Viruses 15, https:\/\/doi.org\/10.3390\/v15051124 (2023).","DOI":"10.3390\/v15051124"},{"key":"10221_CR29","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s13337-014-0207-y","volume":"25","author":"B Ganesh","year":"2014","unstructured":"Ganesh, B., Masachessi, G. & Mladenova, Z. Animal picobirnavirus. Virusdisease 25, 223\u2013238 (2014).","journal-title":"Virusdisease"},{"key":"10221_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-024-09523-6","volume":"24","author":"A Mohebbi","year":"2024","unstructured":"Mohebbi, A. et al. Dental complications as a potential indicator of Redondovirus infection: a cross-sectional study. BMC Infect. Dis. 24, 673 (2024).","journal-title":"BMC Infect. Dis."},{"key":"10221_CR31","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1038\/s41586-024-08562-y","volume":"640","author":"DT McManus","year":"2025","unstructured":"McManus, D. T. et al. An early precursor CD8(+) T cell that adapts to acute or chronic viral infection. Nature 640, 772\u2013781 (2025).","journal-title":"Nature"},{"key":"10221_CR32","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1111\/imr.12064","volume":"254","author":"EM Wilson","year":"2013","unstructured":"Wilson, E. M. & Sereti, I. Immune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairs. Immunol. Rev. 254, 343\u2013354 (2013).","journal-title":"Immunol. Rev."},{"key":"10221_CR33","doi-asserted-by":"publisher","first-page":"3223","DOI":"10.1093\/nar\/gkad199","volume":"51","author":"L Py\u00f6ri\u00e4","year":"2023","unstructured":"Py\u00f6ri\u00e4, L. et al. Unmasking the tissue-resident eukaryotic DNA virome in humans. Nucleic Acids Res. 51, 3223\u20133239 (2023).","journal-title":"Nucleic Acids Res."},{"key":"10221_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2018\/1806374","volume":"32","author":"IA Nasir","year":"2018","unstructured":"Nasir, I. A., Medugu, T. & Dangana, A. Human parvovirus B19-associated hematopathy in HIV disease: need for clinicopathological revisit. J. Biomed. Res. 32, 1\u20132 (2018).","journal-title":"J. Biomed. Res."},{"key":"10221_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1080\/21505594.2022.2029328","volume":"13","author":"Y Yu","year":"2022","unstructured":"Yu, Y., Wan, Z., Wang, J. H., Yang, X. & Zhang, C. Review of human pegivirus: prevalence, transmission, pathogenesis, and clinical implication. Virulence 13, 324\u2013341 (2022).","journal-title":"Virulence"},{"key":"10221_CR36","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1017\/S0950268818000766","volume":"146","author":"KA Bosh","year":"2018","unstructured":"Bosh, K. A. et al. HIV and viral hepatitis coinfection analysis using surveillance data from 15 US states and two cities. Epidemiol. Infect. 146, 920\u2013930 (2018).","journal-title":"Epidemiol. Infect."},{"key":"10221_CR37","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.tim.2012.01.004","volume":"20","author":"N Bhattarai","year":"2012","unstructured":"Bhattarai, N. & Stapleton, J. T. GB virus C: the good boy virus? Trends Microbiol. 20, 124\u2013130 (2012).","journal-title":"Trends Microbiol."},{"key":"10221_CR38","doi-asserted-by":"publisher","DOI":"10.5812\/hepatmon.14169","volume":"14","author":"Y Feng","year":"2014","unstructured":"Feng, Y. et al. GB virus C infection in patients with HIV\/hepatitis C virus coinfection: improvement of the liver function in chronic hepatitis C. Hepat. Mon. 14, e14169 (2014).","journal-title":"Hepat. Mon."},{"key":"10221_CR39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.3851\/IMP1602","volume":"15","author":"C Schwarze-Zander","year":"2010","unstructured":"Schwarze-Zander, C. et al. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(+) T-cells. Antivir. Ther. 15, 745\u2013752 (2010).","journal-title":"Antivir. Ther."},{"key":"10221_CR40","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.01447-22","volume":"10","author":"Y Li","year":"2022","unstructured":"Li, Y. et al. Plasma virome reveals blooms and transmission of anellovirus in intravenous drug users with HIV-1, HCV, and\/or HBV Infections. Microbiol. Spectr. 10, e0144722 (2022).","journal-title":"Microbiol. Spectr."},{"key":"10221_CR41","doi-asserted-by":"publisher","unstructured":"Liu, K. et al. HIV-1 infection alters the viral composition of plasma in men who have sex with men. mSphere 6, https:\/\/doi.org\/10.1128\/mSphere.00081-21 (2021).","DOI":"10.1128\/mSphere.00081-21"},{"key":"10221_CR42","doi-asserted-by":"publisher","first-page":"7037","DOI":"10.1128\/JVI.02366-10","volume":"85","author":"Y Koedel","year":"2011","unstructured":"Koedel, Y., Eissmann, K., Wend, H., Fleckenstein, B. & Reil, H. Peptides derived from a distinct region of GB virus C glycoprotein E2 mediate strain-specific HIV-1 entry inhibition. J. Virol. 85, 7037\u20137047 (2011).","journal-title":"J. Virol."},{"key":"10221_CR43","doi-asserted-by":"publisher","first-page":"15570","DOI":"10.1073\/pnas.0604728103","volume":"103","author":"J Xiang","year":"2006","unstructured":"Xiang, J., McLinden, J. H., Chang, Q., Kaufman, T. M. & Stapleton, J. T. An 85-aa segment of the GB virus type C NS5A phosphoprotein inhibits HIV-1 replication in CD4+ Jurkat T cells. Proc. Natl. Acad. Sci. USA 103, 15570\u201315575 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10221_CR44","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1016\/S0140-6736(04)16453-2","volume":"363","author":"J Xiang","year":"2004","unstructured":"Xiang, J. et al. Inhibition of HIV-1 replication by GB virus C infection through increases in RANTES, MIP-1alpha, MIP-1beta, and SDF-1. Lancet 363, 2040\u20132046 (2004).","journal-title":"Lancet"},{"key":"10221_CR45","doi-asserted-by":"publisher","unstructured":"Ude, I. N., Yeh, S. & Shantha, J. G. Cytomegalovirus retinitis in the highly active anti-retroviral therapy era. Ann. of Eye Sci. 7, https:\/\/doi.org\/10.21037\/aes-21-18 (2022).","DOI":"10.21037\/aes-21-18"},{"key":"10221_CR46","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1097\/QAD.0000000000002484","volume":"34","author":"S Gianella","year":"2020","unstructured":"Gianella, S. et al. Presence of asymptomatic cytomegalovirus and Epstein\u2013Barr virus DNA in blood of persons with HIV starting antiretroviral therapy is associated with non-AIDS clinical events. AIDS 34, 849\u2013857 (2020).","journal-title":"AIDS"},{"key":"10221_CR47","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1080\/14787210.2023.2172400","volume":"21","author":"CP Skipper","year":"2023","unstructured":"Skipper, C. P. & Schleiss, M. R. Cytomegalovirus viremia and advanced HIV disease: is there an argument for anti-CMV treatment? Expert Rev. Anti Infective Ther. 21, 227\u2013233 (2023).","journal-title":"Expert Rev. Anti Infective Ther."},{"key":"10221_CR48","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1097\/00002030-200205030-00005","volume":"16","author":"SJ Stevens","year":"2002","unstructured":"Stevens, S. J., Blank, B. S., Smits, P. H., Meenhorst, P. L. & Middeldorp, J. M. High Epstein-Barr virus (EBV) DNA loads in HIV-infected patients: correlation with antiretroviral therapy and quantitative EBV serology. AIDS 16, 993\u20131001 (2002).","journal-title":"AIDS"},{"key":"10221_CR49","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/0113892029279786240111052824","volume":"25","author":"T Bhagchandani","year":"2024","unstructured":"Bhagchandani, T. et al. Plasma virome of HIV-infected subjects on suppressive antiretroviral therapy reveals association of differentially abundant viruses with distinct T-cell phenotypes and inflammation. Curr. Genom. 25, 105\u2013119 (2024).","journal-title":"Curr. Genom."},{"key":"10221_CR50","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-3-030-03502-0_4","volume":"177","author":"F Lang","year":"2019","unstructured":"Lang, F., Pei, Y., Lamplugh, Z. L. & Robertson, E. S. Molecular biology of EBV in relationship to HIV\/AIDS-associated oncogenesis. Cancer Treat. Res. 177, 81\u2013103 (2019).","journal-title":"Cancer Treat. Res."},{"key":"10221_CR51","doi-asserted-by":"publisher","unstructured":"Zheng, X. et al. Immunosuppressive tumor microenvironment and immunotherapy of Epstein-Barr virus-associated malignancies. Viruses 14, https:\/\/doi.org\/10.3390\/v14051017 (2022).","DOI":"10.3390\/v14051017"},{"key":"10221_CR52","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2561","volume":"34","author":"LOD Oliveira","year":"2024","unstructured":"Oliveira, L. O. D., Costa, I. B. & Quaresma, J. A. S. Association between Epstein-Barr virus LMP-1 and Hodgkin lymphoma LMP-1 mechanisms in Hodgkin lymphoma development. Rev. Med. Virol. 34, e2561 (2024).","journal-title":"Rev. Med. Virol."},{"key":"10221_CR53","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.3389\/fonc.2020.01723","volume":"10","author":"P Shindiapina","year":"2020","unstructured":"Shindiapina, P., Ahmed, E. H., Mozhenkova, A., Abebe, T. & Baiocchi, R. A. Immunology of EBV-related lymphoproliferative disease in HIV-positive individuals. Front. Oncol. 10, 1723 (2020).","journal-title":"Front. Oncol."},{"key":"10221_CR54","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/1627824","volume":"2020","author":"J de Melo Silva","year":"2020","unstructured":"de Melo Silva, J., Pinheiro-Silva, R., Dhyani, A. & Pontes, G. S. Cytomegalovirus and Epstein-Barr infections: prevalence and impact on patients with hematological diseases. BioMed. Res. Int. 2020, 1627824 (2020).","journal-title":"BioMed. Res. Int."},{"key":"10221_CR55","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jcv.2011.12.013","volume":"53","author":"MR Petrara","year":"2012","unstructured":"Petrara, M. R. et al. Epstein-Barr virus load and immune activation in human immunodeficiency virus type 1-infected patients. J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. 53, 195\u2013200 (2012).","journal-title":"J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol."},{"key":"10221_CR56","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1097\/COH.0000000000000875","volume":"19","author":"T Sainz","year":"2024","unstructured":"Sainz, T. & Aldrovandi, G. Pediatric perspective: the microbiome in vertical HIV-infection: unravelling gaps, challenges, and therapeutic potential. Curr. Opin. HIV AIDS 19, 253\u2013260 (2024).","journal-title":"Curr. Opin. HIV AIDS"},{"key":"10221_CR57","doi-asserted-by":"publisher","unstructured":"Chapin-Bardales, J. et al. Hepatitis C virus infection and co-infection with HIV among persons who inject drugs in 10 U.S. cities-national HIV behavioral surveillance, 2018. Int. J. Drug Policy 104387, https:\/\/doi.org\/10.1016\/j.drugpo.2024.104387 (2024).","DOI":"10.1016\/j.drugpo.2024.104387"},{"key":"10221_CR58","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1097\/QAD.0000000000001574","volume":"31","author":"KP Singh","year":"2017","unstructured":"Singh, K. P. et al. HIV-hepatitis B virus coinfection: epidemiology, pathogenesis, and treatment. AIDS 31, 2035\u20132052 (2017).","journal-title":"AIDS"},{"key":"10221_CR59","doi-asserted-by":"publisher","unstructured":"Indari, O. et al. Awakening the sleeping giant: Epstein-Barr virus reactivation by biological agents. Pathog. Dis. 82, https:\/\/doi.org\/10.1093\/femspd\/ftae002 (2024).","DOI":"10.1093\/femspd\/ftae002"},{"key":"10221_CR60","doi-asserted-by":"publisher","unstructured":"Singh, N. & Tscharke, D. C. Herpes simplex virus latency is noisier the closer we look. J. Virol. 94, https:\/\/doi.org\/10.1128\/jvi.01701-19 (2020).","DOI":"10.1128\/jvi.01701-19"},{"key":"10221_CR61","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.chom.2022.03.010","volume":"30","author":"CL Monaco","year":"2022","unstructured":"Monaco, C. L. HIV, AIDS, and the virome: gut reactions. Cell Host Microbe 30, 466\u2013470 (2022).","journal-title":"Cell Host Microbe"},{"key":"10221_CR62","doi-asserted-by":"publisher","unstructured":"K\u00f6ksal, M. O. et al. Interplay between HIV and human pegivirus (HPgV) load in co-infected patients: insights from prevalence and genotype analysis. Viruses 16, https:\/\/doi.org\/10.3390\/v16010005 (2023).","DOI":"10.3390\/v16010005"},{"key":"10221_CR63","doi-asserted-by":"publisher","unstructured":"Querido, S. et al. Kinetics of torque teno virus viral load is associated with infection and de novo donor specific antibodies in the first year after kidney transplantation: a prospective cohort study. Viruses 15, https:\/\/doi.org\/10.3390\/v15071464 (2023).","DOI":"10.3390\/v15071464"},{"key":"10221_CR64","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-021-00185-w","volume":"6","author":"S Mwesigwa","year":"2021","unstructured":"Mwesigwa, S. et al. Unmapped exome reads implicate a role for Anelloviridae in childhood HIV-1 long-term non-progression. NPJ Genom. Med. 6, 24 (2021).","journal-title":"NPJ Genom. Med."},{"key":"10221_CR65","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41572-023-00450-5","volume":"9","author":"I Konstantinidis","year":"2023","unstructured":"Konstantinidis, I. et al. HIV-associated lung disease. Nat. Rev. Dis. Prim. 9, 39 (2023).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10221_CR66","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1164\/rccm.201501-0128OC","volume":"192","author":"JM Beck","year":"2015","unstructured":"Beck, J. M. et al. Multicenter comparison of lung and oral microbiomes of HIV-infected and HIV-uninfected Individuals. Am. J. Respir. Crit. Care Med. 192, 1335\u20131344 (2015).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10221_CR67","doi-asserted-by":"crossref","unstructured":"GBD 2023 Disease and Injury & Risk Factor Collaborators. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet 406, 1873\u20131922 (2025).","DOI":"10.1016\/S0140-6736(25)01637-X"},{"key":"10221_CR68","first-page":"97","volume":"179","author":"HL Twigg 3rd","year":"2017","unstructured":"Twigg, H. L. 3rd, Weinstock, G. M. & Knox, K. S. Lung microbiome in human immunodeficiency virus infection. Transl. Res. J. Lab. Clin. Med. 179, 97\u2013107 (2017).","journal-title":"Transl. Res. J. Lab. Clin. Med."},{"key":"10221_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-91195-2","volume":"11","author":"L Zheng","year":"2021","unstructured":"Zheng, L. et al. Lung microbiome alterations in NSCLC patients. Sci. Rep. 11, 11736 (2021).","journal-title":"Sci. Rep."},{"key":"10221_CR70","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1038\/s41579-021-00536-5","volume":"19","author":"G Liang","year":"2021","unstructured":"Liang, G. & Bushman, F. D. The human virome: assembly, composition and host interactions. Nat. Rev. Microbiol. 19, 514\u2013527 (2021).","journal-title":"Nat. Rev. Microbiol."},{"key":"10221_CR71","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.chom.2020.08.005","volume":"28","author":"T Zuo","year":"2020","unstructured":"Zuo, T. et al. Human-gut-DNA virome variations across geography, ethnicity, and urbanization. Cell Host Microbe 28, 741\u2013751 (2020).","journal-title":"Cell Host Microbe"},{"key":"10221_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-017-0308-0","volume":"5","author":"W Zhang","year":"2017","unstructured":"Zhang, W. et al. Virome comparisons in wild-diseased and healthy captive giant pandas. Microbiome 5, 90 (2017).","journal-title":"Microbiome"},{"key":"10221_CR73","doi-asserted-by":"publisher","DOI":"10.1080\/19490976.2023.2234653","volume":"15","author":"S Bao","year":"2023","unstructured":"Bao, S. et al. Viral metagenomics of the gut virome of diarrheal children with rotavirus A infection. Gut Microbes 15, 2234653 (2023).","journal-title":"Gut Microbes"},{"key":"10221_CR74","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s42003-024-06798-y","volume":"7","author":"X Lu","year":"2024","unstructured":"Lu, X. et al. Metagenomic analysis reveals high diversity of gut viromes in yaks (Bos grunniens) from the Qinghai-Tibet Plateau. Commun. Biol. 7, 1097 (2024).","journal-title":"Commun. Biol."},{"key":"10221_CR75","doi-asserted-by":"publisher","DOI":"10.1002\/imt2.107","volume":"2","author":"S Chen","year":"2023","unstructured":"Chen, S. Ultrafast one-pass FASTQ data preprocessing, quality control, and deduplication using fastp. iMeta 2, e107 (2023).","journal-title":"iMeta"},{"key":"10221_CR76","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/nmeth.1923","volume":"9","author":"B Langmead","year":"2012","unstructured":"Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357\u2013359 (2012).","journal-title":"Nat. Methods"},{"key":"10221_CR77","unstructured":"Li, W. et al. https:\/\/www.ncbi.nlm.nih.gov\/bioproject\/?term=PRJNA1256109 (2025)."},{"key":"10221_CR78","doi-asserted-by":"publisher","unstructured":"Li, W. & Pan, S. K. Figshare, https:\/\/doi.org\/10.6084\/m9.figshare.31048189, (2026).","DOI":"10.6084\/m9.figshare.31048189"},{"key":"10221_CR79","doi-asserted-by":"publisher","unstructured":"Li, W. Zenodo, https:\/\/doi.org\/10.5281\/zenodo.19777507 (2026).","DOI":"10.5281\/zenodo.19777507"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10221-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10221-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10221-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T00:04:08Z","timestamp":1784073848000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-026-10221-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10221"],"URL":"https:\/\/doi.org\/10.1038\/s42003-026-10221-z","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"assertion":[{"value":"21 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"958"}}